Trials / Completed
CompletedNCT00000236
Buprenorphine Pharmacology Related to Addiction Treatment - 18
Buprenorphine Pharmacology Related to Addiction Treatment
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to examine the interactions between buprenorphine and naltrexone, and to assess how they may directly impact the clinical issues involving: transferring patients from buprenorphine to naltrexone, developing a non-abusable form of buprenorphine, and enhancing patient acceptability of naltrexone.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine/naloxone |
Timeline
- First posted
- 1999-09-21
- Last updated
- 2005-08-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000236. Inclusion in this directory is not an endorsement.